Cardiac Inflammation Test (CIT)

The Cardiac Inflammation Test (CIT) provides a convenient and accessible means for healthcare professionals to screen essential metabolic health markers in their patients.

While cholesterol levels, including high-density lipoprotein (HDL) and low-density lipoprotein (LDL), fasting glucose, and HbA1c, are well-researched indicators of cardiac health and diabetes risk, they are often overlooked in routine screenings. However, monitoring these markers can provide critical insights into a patient's health and potential risk factors for many health concerns.

Why are Lp(a) and ApoB important?

Lp(a) is a significant genetic risk factor for cardiovascular disease, contributing to arterial plaque buildup and inflammation. Elevated levels of Lp(a) can increase the risk of heart attack and stroke, independent of other cholesterol measurements. Identifying high Lp(a) levels can help clinicians assess a patient's true cardiovascular risk and tailor preventative strategies more effectively.

ApoB, on the other hand, is a key component of lipoproteins that transport cholesterol in the bloodstream. Each ApoB-containing particle, including LDL, is atherogenic, meaning it can potentially contribute to plaque development in the arteries. Monitoring ApoB levels provides a more precise picture of a patient’s lipid profile and cardiovascular risk than traditional cholesterol tests alone.

By including these markers in our innovative CIT, we empower healthcare providers to make more informed decisions regarding patient care, enabling timely interventions that can significantly impact long-term health outcomes.

Key Markers: Total cholesterol , ratios, HDL, LDL , Trigycerides, ApoB Lp(a), hs-CRP, HbA1C, Glucose, homocysteine 

Sample Type: Dried Blood Spot

Turnaround Time: 3 weeks 

Sample Report

Blood Spot Validation